| |
|
|
|
ImmuCell Corporation  
|
|
8.4 -0.27 (-0.05%) |
09-25 16:00 |
|
Open: |
8.67 |
Pre close: |
8.84 |
Target:
|
10.79
|
|
High: |
8.78 |
Low: |
8.31 |
Resistance:
|
9.24
10.79
|
|
Volume: |
5,231 |
Market Cap: |
46M |
Support:
|
7.68
 6.71
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.42
|
MACD |
MACD(12,26):
|
0.43  |
|
MA(20): |
7.71 |
Signal(12,26,9): |
0.35 |
|
MA(100): |
7.15 |
Stochastic Oscillator |
%K(14,3):
|
79.64 |
|
MA(250): |
7.45 |
%D(3): |
73.55 |
|
Average Volume(K) |
3-Month: |
829
|
52-Week |
High:
|
9.25 |
|
10-Days: |
2011 |
Low: |
6.35 |
|
RSI |
RSI(14):
|
59.96 |
Change(%): |
30.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-7.2 |
Shares Out. (M) |
5.48 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-5.1 |
Shares Float (M) |
4.08 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
72.3 |
% Held by Institutions |
11.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
8 |
|
Book Value (p.s.) |
1.980 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.24 |
|
Profit Margin |
-14.23 |
Operating Cash Flow
(M) |
0.35 |
P/S |
21920000.00 |
|
Operating Margin |
-11.49 |
Levered Free Cash Flow
(M) |
-12.95 |
P/CF |
132.95 |
|
|
|
|
|
|
